Skip to main content

Bank of New York Mellon Corp

Bank

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in ACRS

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$776,339
+$163,754 QoQ
Shares Held
207,024
+1.7% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 86.89282402040344.ToString("F0")% Shared 0.ToString("F0")% None 13.107175979596569.ToString("F0")%

Common Shares in ACRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. ACRS ranks #185 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $776,339 207,024
2025-12-31 $612,585 203,517
2025-09-30 $418,154 220,082
2025-06-30 $305,671 215,262
2025-03-31 $20,766 13,573
2024-03-31 $288,635 232,771
2023-12-31 $296,489 282,371
2023-09-30 $1,662,973 242,770
2023-06-30 $2,513,956 242,426
2023-03-31 $1,862,882 230,270
2022-12-31 $3,647,903 231,613
2022-09-30 $3,681,301 233,882
2022-06-30 $2,822,696 202,199
2022-03-31 $3,199,674 185,596
2021-12-31 $2,709,121 186,322
2021-09-30 $3,280,410 182,245
2021-06-30 $2,374,849 135,242
2021-03-31 $2,801,130 111,156
2020-09-30 $280,676 109,213
2020-06-30 $176,924 109,213
2020-03-31 $226,492 217,783